The expert panel of India's apex drug regulator recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.

According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E's Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.